AtheroNova and its potential licensing partners are subject to many laws and regulations, and any adverse regulatory action may affect the Company???s ability to exploit its IP. Developing, manufacturing, and marketing regulated medical products and pharmaceuticals are subject to extensive and rigorous regulation by numerous government and regulatory agencies, including the FDA and comparable fore